CNTN

Canton Strategic Holdings, Inc.

A New Jersey company running a "digital asset treasury" around the Canton Network, a privacy-focused blockchain for institutional finance, where it operates as a "Super Validator" managing Canton Coin. It began in 2017 as Tharimmune, a biotech working on a treatment for the severe itching of liver disease, before pivoting and rebranding in early 2026. The name nods to Switzerland's cantonal system, whose semi-independent regions work together like one country — much like the network's own design.